Study: ADT tied to higher A1C levels in men with diabetes

03/6/2013 | MedWire News (U.K.)

Male diabetes patients who underwent androgen deprivation therapy for prostate cancer showed higher A1C at two years compared with those who did not receive ADT, a study found. "Men with diabetes who start ADT should be counseled about the potential need for intensification of diabetes therapy and should have their [A1C] levels monitored during therapy, especially if they continue on long-term ADT," researchers wrote in the journal European Urology.

View Full Article in:

MedWire News (U.K.)

Published in Brief:

SmartBrief Job Listings for Health Care

Job Title Company Location
Senior Director Medical Affairs
Edwards Lifesciences
Irvine, CA
Senior Scientist - Cell Engineering Group
Pfizer
San Francisco, CA
Medical Director - Physician
Willamette Valley Community Health
Salem, OR
Area Reimbursement Manager (CT, MA, MD, ME, NH, NJ, NY, PA, VT)
SI-BONE, INC
Multiple Locations, SL_Multiple Locations
Medical Director - Physician
Willamette Valley Community Health
Salem, OR